Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

International, Prospective Study Comparing Nilotinib Versus Imatinib with Early Switch to Nilotinib to Obtain Sustained Treatment-Free Remission in Patients with Chronic Myeloid Leukemia (SUSTRENIM Trial): Analysis of the Eligibility to Treatment Discontinuation

Fabrizio Pane,Fausto Castagnetti,Alfonso Piciocchi,Elisabetta Abruzzese,Renato Bassan,Gianni Binotto,Massimiliano Bonifacio,Giovanni Caocci,Francesco Cavazzini,Giuseppe Cimino,Antonella Gozzini,Monia Lunghi,Roberto Marasca,Bruno Martino,Francesco Muriano,Gianantonio Rosti,Antonella Russo Rossi,Simona Sica,Agostino Tafuri,Daniele Vallisa,Monica Messina,Francesca Paola Paoloni,Paola Fazi,Peter E. Westerweel,Jeroen J. W. M. Janssen,Giuseppe Saglio,Massimo Breccia

BLOOD（2023）

Cited 0|Views17
Key words
Treatment Discontinuation,Nilotinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined